Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2010 Jan;62(1):1-5.
doi: 10.1002/art.25039.

Good and bad memories following rituximab therapy

Editorial

Good and bad memories following rituximab therapy

E William St Clair. Arthritis Rheum. 2010 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JCW. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54:613–620. - PubMed
    1. Bingham C, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, et al. Immunixation responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial (SIERRA) Arthritis Rheum. 2009;xx:xx–xx. - PubMed
    1. van Assen S, Holvast A, Benne C, Posthumus MD, van Leeuwen MA, Voskuyl A, et al. Humoral responses after influenza-vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum. 2009;xx:xx–xx. - PubMed
    1. Takahashi Y. Memory B cells in systemic and mucosal immune response: implications for successful vaccination. Biosci Biotechnol Biochem. 2007;71:2358–2366. - PubMed
    1. Keystone E, Fleischmann R, Emery P, Furst DE, van Vollenhoven R, Bathon J, et al. Safety and efficacy of additional course of rituximab in patients with active rheumatoid arthritis. An open-label extension analysis. Arthritis Rheum. 2007;56:3896–3908. - PubMed

MeSH terms